Moderna, Inc. (MRNA)
Healthcare · Biological Products, (No Diagnostic Substances)
Moderna, Inc. (MRNA) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| BANQUE PICTET & CIE SA | 2,151,259 | $414.27M | 0.54% |
| Douglas Lane & Associates, LLC | 1,160,945 | $223.56M | 0.29% |
| Lingotto Investment Management LLP | 749,208 | 44.27M | 0.19% |
| Pictet Asset Management Holding SA | 446,265 | $89.13M | 0.11% |
| Candriam S.C.A. | 384,828 | $74.38M | 0.10% |
| PRINCIPAL FINANCIAL GROUP INC | 380,807 | $73.33M | 0.10% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 250,496 | $48.2K | 0.06% |
| MACKENZIE FINANCIAL CORP | 225,823 | $43.49M | 0.06% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-10-15 | Hoge Stephen | President | Sale | $8.64M |
| 2026-10-14 | Hoge Stephen | President | Sale | $8.28M |
| 2026-10-14 | Hoge Stephen | President | Sale | $96.4K |
| 2026-09-15 | Hoge Stephen | President | Sale | $5.88M |
| 2026-09-14 | Hoge Stephen | President | Sale | $5.81M |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sale | $2.67M |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sale | $2.02M |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Sale | $485.8K |